CC - The Chemours Company

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Revenue 6,638,000 6,183,000 5,400,000 5,717,000
Cost of Revenue 4,667,000 4,438,000 4,297,000 4,762,000
Gross Profit 1,971,000 1,745,000 1,103,000 955,000
Operating Expenses
Research Development 82,000 81,000 81,000 97,000
Selling General and Administrative 684,000 660,000 631,000 632,000
Non Recurring - - - -
Others - - - -
Total Operating Expenses 5,433,000 5,179,000 5,009,000 5,491,000
Operating Income or Loss 1,205,000 1,004,000 391,000 226,000
Income from Continuing Operations
Total Other Income/Expenses Net -50,000 -92,000 -402,000 -414,000
Earnings Before Interest and Taxes 1,205,000 1,004,000 391,000 226,000
Interest Expense -195,000 -214,000 -219,000 -132,000
Income Before Tax 1,155,000 912,000 -11,000 -188,000
Income Tax Expense 159,000 165,000 -18,000 -98,000
Minority Interest 6,000 5,000 4,000 4,000
Net Income From Continuing Ops 996,000 747,000 7,000 -90,000
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income 995,000 746,000 7,000 -90,000
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares 995,000 746,000 7,000 -90,000